Investment Summary |
|
|---|---|
| Date | 2021-10-04 |
| Target | Trigal Pharma |
| Sector | Life Science |
| Investor(s) | KD Pharma Group |
| Deal Type | Stake Purchase |
SEARCH BY
KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation, and encapsulation services. KD Pharma Group was founded in 1988 and is based in Bioggio, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Austria M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-25 |
dsm-firmenich s Marine Lipids Omega-3 Business
Kaiseraugst, Switzerland dsm-firmenich's Marine Lipids Omega-3 Business provides fish oil omega-3 business for the dietary supplement and pharma markets, together with the production facilities in Piura, Peru, and Mulgrave, Canada. |
Buy | - |
